Cormorant Asset Management, LP - PHASEBIO PHARMACEUTICALS INC ownership

Back to all holdings Add to watchlist

PHASEBIO PHARMACEUTICALS INC's ticker is PHAS and the CUSIP is 717224109. A total of 52 filers reported holding PHASEBIO PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.1%.

Links
Filings
External links
Quarter-by-quarter ownership
Cormorant Asset Management, LP ownership history of PHASEBIO PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2019$3,405,000
-71.4%
816,448
-9.9%
0.21%
-69.7%
Q2 2019$11,890,000
+48.9%
906,229
+7.9%
0.68%
+26.5%
Q1 2019$7,985,000
+135.3%
839,642
-23.5%
0.54%
+96.4%
Q4 2018$3,393,000–1,097,926–0.28%–
 Download
Other shareholders

There were no reported owners of PHASEBIO PHARMACEUTICALS INC in Q4 2019.

NameSharesValueWeighting ↓
View complete list of PHASEBIO PHARMACEUTICALS INC shareholders